|Bid||97.79 x 900|
|Ask||97.93 x 1000|
|Day's Range||96.94 - 99.63|
|52 Week Range||86.34 - 142.64|
|Beta (5Y Monthly)||1.34|
|PE Ratio (TTM)||30.74|
|Earnings Date||Jan 31, 2022 - Feb 04, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||159.46|
It might be of some concern to shareholders to see the Catalent, Inc. ( NYSE:CTLT ) share price down 11% in the last...
View more earnings on CTLTSee more from BenzingaWhy Erytech Pharma Are Shares Moving Higher TodayDon't miss real-time alerts on your stocks - joinBenzinga Profor free! Try the tool that will help you invest smarter, faster, and better.© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Catalent's (CTLT) robust performance across most of its segments drives its third-quarter fiscal 2022 top line.